Sleep medicine pharmacotherapeutics overview: Today, tomorrow, and the future (Part 1: Insomnia and circadian rhythm disorders)

Research output: Contribution to journalArticle

Abstract

Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.

Original languageEnglish (US)
Pages (from-to)1659-1668
Number of pages10
JournalChest
Volume142
Issue number6
DOIs
StatePublished - Dec 2012

Fingerprint

Chronobiology Disorders
Sleep Initiation and Maintenance Disorders
Sleep
Medicine
Therapeutics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Sleep medicine pharmacotherapeutics overview : Today, tomorrow, and the future (Part 1: Insomnia and circadian rhythm disorders). / Gulyani, Seema; Salas, Rachel; Gamaldo, Charlene.

In: Chest, Vol. 142, No. 6, 12.2012, p. 1659-1668.

Research output: Contribution to journalArticle

@article{e06cdcb8b7f0448280c5416436b73c87,
title = "Sleep medicine pharmacotherapeutics overview: Today, tomorrow, and the future (Part 1: Insomnia and circadian rhythm disorders)",
abstract = "Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.",
author = "Seema Gulyani and Rachel Salas and Charlene Gamaldo",
year = "2012",
month = "12",
doi = "10.1378/chest.12-0465",
language = "English (US)",
volume = "142",
pages = "1659--1668",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Sleep medicine pharmacotherapeutics overview

T2 - Today, tomorrow, and the future (Part 1: Insomnia and circadian rhythm disorders)

AU - Gulyani, Seema

AU - Salas, Rachel

AU - Gamaldo, Charlene

PY - 2012/12

Y1 - 2012/12

N2 - Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.

AB - Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.

UR - http://www.scopus.com/inward/record.url?scp=84870602082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870602082&partnerID=8YFLogxK

U2 - 10.1378/chest.12-0465

DO - 10.1378/chest.12-0465

M3 - Article

C2 - 23208340

AN - SCOPUS:84870602082

VL - 142

SP - 1659

EP - 1668

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -